Close Menu

NEW YORK – Truvian Sciences announced Wednesday that it has closed a $27.1 million Series B financing round to support the company's development of an automated benchtop system to provide lab accurate results in 20 minutes.

The financing round was led by GreatPoint Ventures and included DNS Capital, Tao Capital Partners, and existing investor Domain Associates. San Diego-based Truvian has raised $46.3 million since its founding in 2015, it said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.